MONRO, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data MONRO, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	1,022	1,128	1,200	1,257	1,126	1,359	1,325	1,277	1,195	1,157
Gross profit	397	436	465	477	395	482	456	452	418	405
Operating income	116	127	127	102	72.2	101	79.8	71.4	12.6	20
Other non-operating income	0.63	0.45	0.63	0.79	0.19	0.62	0.59	0.46	0.45	0.3
Pre-tax income	97.2	103	100	74.3	44.2	77.3	57.2	51.9	-5.91	3.1
Income tax	35.7	39.5	20.6	16.3	9.87	15.7	18.1	14.3	-0.73	0.93
Net income	61.5	63.9	79.8	58	34.3	61.6	39	37.6	-5.18	2.17
EBITDA	161	177	182	167	150	182	157	144	81.9	81.7
EPS, basic	1.88	1.94	2.41	1.73	1.02	1.82	1.20	1.18	-0.22	0.03
EPS, diluted	1.85	1.92	2.37	1.71	1.01	1.81	1.20	1.18	-0.22	0.03
Shares, basic (weighted)	32.4	32.8	33	33.2	33.3	33.5	32.1	30.9	29.9	30
Shares, diluted (weighted)	33.3	33.3	33.7	34	33.9	34	32.7	31.9	29.9	30
Dividend per share	0.68	0.72	0.80	0.88	0.88	1.02	1.12	1.12	1.12	1.12

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	9	1.91	6.21	345	30	7.95	4.88	6.56	20.8	14.6
Inventory	143	152	171	187	162	166	147	154	181	155
Other current assets	18.3	21.1	28.3	24.3	16	16	31.9	29.9	19.3	12
Total current assets	199	207	240	596	267	246	258	253	277	237
Property, plant and equipment	395	417	313	329	327	315	305	280	259	242
Lease right-of-use assets				200	203	214	211	203	182	176
Goodwill	502	523	672	672	690	777	736	736	736	736
Intangible assets	54.3	49.1	51.1	29.8	26.1	26.7	16.6	13.3	10.4	7.72
Other non-current assets	11.3	11	13	20.7	18.3	20.2	29.4	19.2	17.3	16.4
Total assets	1,185	1,218	1,312	2,049	1,812	1,871	1,777	1,693	1,642	1,568
Accounts payable	79.5	84.6	104	99.5	112	132	262	252	323	314
Accrued liabilities	25	20.2	20.2	14.4	20.8	18.5	16	21.2	23.6	21.9
Deferred revenue		11.9	12.1	13.1	12	14.2	15.4	15.2	14.7	13.2
Short-term debt	0.02	0.04	0.04	32.3	37.8	42.1	40	38.2	39.7	36.8
Total current liabilities	186	194	218	255	291	322	449	455	524	518
Long-term debt	182	148	138	566	190	176	105	102	61.3	60
Lease liabilities				171	178	193	191	182	168	156
Other non-current liabilities	15.1	14.1	12.7	12.9	16.6	10.8	10.7	10.6	10.1	11.1
Total liabilities	604	590	613	1,315	1,062	1,089	1,082	1,036	1,021	977
Total debt	182	148	138	566	190	177	105	102	61.3	60
Paid-in capital	192	200	220	230	238	245	251	254	259	262
Retained earnings	499	539	592	620	624	651	654	655	615	582
Treasury stock	-106	-107	-109	-109	-109	-109	-206	-250	-250	-250
Other comprehensive income	-3.16	-4.25	-4.54	-6.89	-4.62	-4.49	-4.12	-3.45	-3.42	-2.92
Total equity	581	628	700	734	750	783	695	657	621	591
Total liabilities and equity	1,185	1,218	1,312	2,049	1,812	1,871	1,777	1,693	1,642	1,568

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	61.5	63.9	79.8	58	34.3	61.6	39	37.6	-5.18	2.17
Depreciation and amortization	44.6	49.3	55.5	65	77.3	81.2	77	72.2	69.4	61.7
Stock-based compensation	2.48	2.86	4.02	3.81	2.39	4.33	5.65	4.31	4.71	3.87
Deferred income tax	11.3	15.5	12.5	11.5	10.9	14	4.24	9.03	0.14	0.88
Change in inventory	5.04	-8.4	-9.13	-11.8	26.6	-2.39	-18.2	-6.35	-27	23.1
Cash from operations	130	121	153	121	185	174	215	125	132	70.4
Capital expenditures	-34.6	-39.1	-44.5	-55.9	-51.7	-27.8	-39	-25.5	-26.4	-31.7
Acquisitions	-143	-23.4	-62.4	-104	-17.2	-83.3	-6.69
Cash from investing	-176	-58.5	-106	-159	-66.3	-110	26.5	-1.96	-1.23	-1.2
Debt issued								156	205	169
Stock issued	3.49	4.82	14.6	6.17	6.28	2.14	0.73	0.02
Share buybacks							-96.9	-44
Dividends paid	-22.5	-24	-26.8	-29.7	-29.8	-34.7	-36.4	-35.5	-34.9	-35
Cash from financing	46.7	-69.8	-42.7	377	-434	-86	-245	-122	-116	-75.4
Net change in cash	1.01	-7.09	4.31	339	-316	-22	-3.06	1.68	14.2	-6.13
Free cash flow	95.3	82.1	108	65.4	133	146	176	99.7	106	38.8
Interest paid	18.4	22.8	25.4	27.3	26.4	24.3	22.9	19.9	18.4	16.4
Income taxes paid	24.8	25.2	9.68	12.7	2.33	-11.6	16.9	5.3	4	0.24

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $13.74 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	35.0%	Gross profit / revenue.
Operating margin	1.7%	Operating income / revenue.
EBITDA margin	7.1%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	0.3%	Pre-tax income / revenue.
Net margin	0.2%	Net income / revenue.
FCF margin	3.4%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	6.1%	Cash from operations / revenue.
Effective tax rate	29.9%	Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)	0.1%	Net income / average total assets.
Stock-based pay / revenue	0.3%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.7%	Capital expenditures / revenue.
D&A / revenue	5.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-3.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-4.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	0.6%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-3.0%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-3.9%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	0.5%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	59.4%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-36.9%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-22.6%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-0.3%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-19.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-11.4%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income CAGR, 3y	-61.8%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-42.4%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS CAGR, 3y	-70.8%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-50.5%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-46.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-31.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-17.6%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-63.3%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-39.6%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-21.9%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	0.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	4.9%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-4.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-4.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-2.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-2.8%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-2.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.46x	Current assets / current liabilities.
Quick ratio	0.03x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.03x	(Cash + short-term investments) / current liabilities.
Debt / assets	3.8%	Total debt / total assets.
Liabilities / assets	62.3%	Total liabilities / total assets.
Net debt	$45.4M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	0.56x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	-$281.2M	Current assets - current liabilities.
Goodwill and intangibles / assets	47.5%	(Goodwill + intangible assets) / total assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.72x	Revenue / average total assets.
Fixed asset turnover	4.62x	Revenue / average property, plant and equipment.
FCF conversion	1,785.0%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	44.9%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.03	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$0.03	Net income per basic share, as reported (split-adjusted).
Revenue per share	$38.57	Revenue / diluted weighted shares.
FCF per share	$1.29	Free cash flow / diluted weighted shares.
Operating cash flow per share	$2.35	Cash from operations / diluted weighted shares.
Cash per share	$0.49	(Cash + short-term investments) / shares outstanding.
Dividend per share	$1.12	Dividend declared per common share (paid, when declared is not tagged).
Payout ratio	1,609.0%	Dividends paid / net income, when net income is positive.
Dividends / FCF	90.1%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$429.6M	Share price x shares outstanding.
Enterprise value	$474.9M	Market cap + total debt - cash - short-term investments.
P/E	198x	Market cap / net income. Only when net income is positive.
P/S	0.37x	Market cap / revenue.
P/FCF	11.1x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	6.10x	Market cap / cash from operations, when positive.
EV/Sales	0.41x	Enterprise value / revenue.
EV/EBIT	23.7x	Enterprise value / operating income, when both are positive.
EV/EBITDA	5.81x	Enterprise value / EBITDA, when both are positive.
EV/FCF	12.2x	Enterprise value / free cash flow, when both are positive.
FCF yield	9.0%	Free cash flow / market cap.
Earnings yield	0.5%	Net income / market cap (the inverse of P/E).
Dividend yield	8.1%	Dividends paid over the period / market cap.
Shareholder yield	8.1%	(Dividends paid + share buybacks) / market cap.

What was MONRO, INC.'s revenue in fiscal 2026?

MONRO, INC. reported revenue of $1.16B for fiscal 2026, 3.2% lower than the year before.

Was MONRO, INC. profitable in fiscal 2026?

Yes. Net income was $2.2M, a net margin of 0.2%.

How much free cash flow did MONRO, INC. generate in fiscal 2026?

Cash from operations of $70.4M minus capital expenditures of $31.7M left free cash flow of $38.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to MONRO, INC.